arrow
T

Takashi Saito

riken center for brain science
H指数:70
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

APOE3 and APOE4 human astrocytes differentially modulate Alzheimer's disease pathology and microglial responses in chimeric mice

APOE3和APOE4人星形胶质细胞在嵌合小鼠中差异调节阿尔茨海默病病理和微胶质细胞反应

2026-08-010
OAAI
Early and progressive retinal microglial changes in APPNL-F/NL-F mouse model of Alzheimer’s disease revealed by an automated image analysis software

通过自动图像分析软件揭示的appnl-f/nl-f小鼠阿尔茨海默氏病模型的早期和进行性视网膜小胶质细胞变化

2026-01-300
OAAI
Somatostatin receptor subtypes 1 and 4 regulate neprilysin, the major amyloid-β degrading enzyme in brain

生长抑素受体亚型1和4调节脑内主要的淀粉样蛋白-β降解酶——中性内肽酶。

2025-11-190
PRE
In vivo hyperphosphorylation of tau is associated with synaptic loss and behavioral abnormalities in the absence of tau seeds

在缺乏tau种子的情况下,tau的体内过度磷酸化与突触丢失和行为异常相关。

2024-12-240
OAAI
GLP-1 receptor signaling restores aquaporin 4 subcellular polarization in reactive astrocytes and promotes amyloid β clearance in a mouse model of Alzheimer's disease

GLP-1受体信号通路恢复了反应性星形胶质细胞中水通道蛋白4的亚细胞极化,并促进了阿尔茨海默病小鼠模型中β-淀粉样蛋白的清除。

2024-12-011
OAAI
Machine learning reveals prominent spontaneous behavioral changes and treatment efficacy in humanized and transgenic Alzheimer's disease models

机器学习在人源化和转基因阿尔茨海默病模型中揭示了显着的自发行为变化和治疗效果

2024-11-010
OAAI
Metabolic resistance of Aβ3pE-42, a target epitope of the anti-Alzheimer therapeutic antibody, donanemab
2024-09-300
OA